Crohn-betegség: vizsgálatok itt: Szingapúr

2 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  Where

  Singapore

  Életkor

  16 év to 80 év

  People

  1200 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06430801 · EU 2023-508636-61-00
• 2. fázisTaking people
  Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  Where

  Singapore

  Életkor

  18 év to 75 év

  People

  590 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06548542 · EU 2024-513009-30-00